Samrat Pharmachem Ltd PE Ratio

Samrat Pharmachem PE Ratio

Image

Samrat Pharmachem Ltd

NSE: SAMRATPHARMA

PE

-

Last updated on: Feb 21, 2026

Key Highlights

  • The P/E Ratio of Samrat Pharmachem Ltd is 0 as of 21 Feb 15:30 PM The P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years .

Historical P/E Ratio of Samrat Pharmachem Ltd

No data available

Company Fundamentals for Samrat Pharmachem Ltd

Image

Samrat Pharmachem Ltd

NSE: SAMRATPHARMA

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Samrat Pharmachem Ltd

1M

1Y

3Y

5Y

Monitoring Samrat Pharmachem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 2026202
19 Feb 2026201.05
18 Feb 2026205.75
17 Feb 2026208.65
16 Feb 2026216.1
13 Feb 2026238.6
12 Feb 2026234.1
11 Feb 2026240.35
10 Feb 2026245.3
09 Feb 2026237.85

BlinkX Score for Samrat Pharmachem Ltd

Asset Value vs Market Value of Samrat Pharmachem Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Samrat Pharmachem Ltd62.41
Sun Pharmaceutical Industries Ltd413753
Divis Laboratories Ltd167032
Torrent Pharmaceuticals Ltd143426
Cipla Ltd108360
Dr Reddys Laboratories Ltd106859

Key Valuation Metric of Samrat Pharmachem Ltd

X

Historical Market Cap of Samrat Pharmachem Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Samrat Pharmachem Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Samrat Pharmachem Ltd

No data available

* All values are in %

About Samrat Pharmachem Ltd

  • Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
  • Since then, it envisioned to focus on lodine Derivatives as their core products.
  • The Company's principal activities are manufacturing and selling chemicals.
  • Company is a producer of pharmaceutical chemicals.
  • The intermediates produced are used in pharmaceutical and chemical industries.

Samrat Pharmachem Ltd News Hub

Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter

Net profit of Samrat Pharmachem rose 239.34% to Rs 2.07 crore in the quarter ended June 2024 as agai

Read more

13 Aug 24

Samrat Pharmachem announces board meeting date

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024.

Read more

28 Sept 24

Samrat Pharmachem to declare Quarterly Result

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2025.

Read more

31 Dec 24

Samrat Pharmachem reports standalone net profit of Rs 2.66 crore in the September 2024 quarter

Net profit of Samrat Pharmachem reported to Rs 2.66 crore in the quarter ended September 2024 as aga

Read more

15 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions